scholarly article | Q13442814 |
P50 | author | Salomon Amar | Q38326147 |
Olivier Huck | Q59684060 | ||
P2093 | author name string | Bin Cai | |
Jayesh Patel | |||
Jacob Al-Hashemi | |||
James Panek | |||
Abdulsalam Alshammari | |||
P2860 | cites work | Porphyromonas gingivalis-host interactions: open war or intelligent guerilla tactics? | Q24655246 |
Animal models to study host-bacteria interactions involved in periodontitis | Q26863436 | ||
Measuring the chemical and cytotoxic variability of commercially available kava (Piper methysticum G. Forster) | Q28544673 | ||
Identification and characterization of kava-derived compounds mediating TNF-alpha suppression | Q33470666 | ||
Constituents in kava extracts potentially involved in hepatotoxicity: a review | Q34179570 | ||
Proposal for a kava quality standardization code. | Q34200446 | ||
Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. | Q34470176 | ||
Kava consumption and its health effects. | Q34586850 | ||
TLR2-dependent modulation of osteoclastogenesis by Porphyromonas gingivalis through differential induction of NFATc1 and NF-kappaB. | Q35085107 | ||
Kava: an overview | Q35555096 | ||
Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis | Q36228512 | ||
Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic rats | Q36328094 | ||
The use of rodent models to investigate host-bacteria interactions related to periodontal diseases | Q37058550 | ||
Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells | Q37172061 | ||
Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss | Q37421374 | ||
Cytokine regulation of immune responses to Porphyromonas gingivalis | Q37780271 | ||
Does adjunctive antimicrobial therapy reduce the perceived need for periodontal surgery? | Q37816540 | ||
What can the periodontal community learn from the pathophysiology of rheumatoid arthritis? | Q37842638 | ||
Surgical and nonsurgical periodontal therapy. Learned and unlearned concepts | Q38097942 | ||
Systemic medication and the inflammatory cascade | Q38169806 | ||
Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF. | Q38600636 | ||
Cytokines during periodontal wound healing: potential application for new therapeutic approach | Q38761962 | ||
Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: a systematic review and meta-analysis. | Q38771457 | ||
Risk factors in periodontology: a conceptual framework. | Q39012939 | ||
Suppression of iNOS and COX-2 expression by flavokawain A via blockade of NF-κB and AP-1 activation in RAW 264.7 macrophages | Q39145051 | ||
Variable cell responses to P. gingivalis lipopolysaccharide | Q39802848 | ||
Inhibition of TNFalpha-induced activation of nuclear factor kappaB by kava (Piper methysticum) derivatives | Q40319593 | ||
Identification and Characterization of MicroRNA Differentially Expressed in Macrophages Exposed to Porphyromonas gingivalis Infection | Q40378814 | ||
Two complementary methods of assessing periodontal bone level in rats | Q41212610 | ||
Assessment of collagen antibody-induced arthritis in BALB/c mice using bioimaging analysis and histopathological examination | Q41387703 | ||
RANKL expression in periodontal disease: where does RANKL come from? | Q42409559 | ||
Omega-3 fatty acid regulates inflammatory cytokine/mediator messenger RNA expression in Porphyromonas gingivalis-induced experimental periodontal disease | Q44090230 | ||
Follicular dendritic cell-secreted protein is decreased in experimental periodontitis concurrently with the increase of interleukin-17 expression and the Rankl/Opg mRNA ratio. | Q44823696 | ||
Inducible nitric oxide synthase (iNOS) in gingival tissues of chronic periodontitis with and without diabetes: immunohistochemistry and RT-PCR study | Q46763936 | ||
Prevalence of periodontitis in adults in the United States: 2009 and 2010. | Q47203547 | ||
COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats | Q57219768 | ||
Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis | Q82547569 | ||
COX-2 is associated with periodontitis in Europeans | Q83002513 | ||
Analysis of TNF-α (-308) polymorphism and gingival crevicular fluid TNF-α levels in aggressive and chronic periodontitis: A preliminary report | Q86649789 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | periodontitis | Q520127 |
Porphyromonas gingivalis | Q3214147 | ||
P1104 | number of pages | 10 | |
P304 | page(s) | 1123-1132 | |
P577 | publication date | 2017-09-21 | |
P1433 | published in | Journal of Clinical Periodontology | Q15638559 |
P1476 | title | Kava-241 reduced periodontal destruction in a collagen antibody primed Porphyromonas gingivalis model of periodontitis | |
P478 | volume | 44 |
Q99233987 | A therapeutic oxygen carrier isolated from Arenicola marina decreased P. gingivalis induced inflammation and tissue destruction |
Q64096419 | Contribution of Statins towards Periodontal Treatment: A Review |
Q90045025 | Identification of a Kavain Analog with Efficient Anti-inflammatory Effects |
Q90425113 | Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling |
Q64121668 | Proposal for a novel murine model of human periodontitis using and type II collagen antibody injections |
Q89143075 | Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model |
Q64069168 | Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications |
Search more.